Table 2 Associations between clinical variables and amygdalar metabolic activity at baseline
From: Clinical and biochemical factors associated with amygdalar metabolic activity
Parameters | Univariate | Multivariate | ||
---|---|---|---|---|
β | P value | β | P value | |
Gendera | −0.073 | 0.177 | - | - |
Age | 0.017 | 0.760 | - | - |
Body weight | 0.030 | 0.576 | - | - |
Waist circumference | 0.027 | 0.616 | - | - |
Body mass index | 0.036 | 0.504 | - | - |
Heart rate | 0.082 | 0.128 | - | - |
Systolic blood pressure | 0.023 | 0.666 | - | - |
Diastolic blood pressure | 0.016 | 0.773 | - | - |
Aspartate transaminaseb | 0.043 | 0.425 | - | - |
Alanine transaminaseb | 0.069 | 0.200 | - | - |
γ-glutamyl transferaseb | 0.101 | 0.061 | - | - |
LDL cholesterol | 0.000 | 0.995 | - | - |
HDL cholesterol | −0.089 | 0.097 | - | - |
Triglyceridesb | 0.063 | 0.244 | - | - |
Fasting plasma glucoseb | 0.251 | <0.001 | 0.204 | <0.001 |
Fasting immunoreactive insulinb | 0.094 | 0.080 | - | - |
Glycated hemoglobin | 0.217 | <0.001 | 0.048 | 0.573 |
Estimated glomerular filtration rate | −0.003 | 0.954 | - | - |
Uric acid | 0.092 | 0.087 | - | - |
High-sensitivity CRPb | 0.062 | 0.273 | - | - |
ADMAb | 0.114 | 0.034 | - | - |
PEDFb | 0.027 | 0.621 | - | - |
Visceral adipose tissue area | 0.031 | 0.630 | - | - |
Subcutaneous adipose tissue area | 0.028 | 0.662 | - | - |
Current smokinga | −0.028 | 0.603 | - | - |
Coronary artery diseasea | 0.211 | <0.001 | 0.142 | 0.010 |
Cerebrovascular injurya | 0.076 | 0.158 | - | - |
Aspirina | 0.134 | 0.013 | - | - |
Statinsa | 0.091 | 0.092 | - | - |
Medication for hypertensiona | 0.019 | 0.725 | - | - |
Oral hypoglycemic agentsa | 0.186 | <0.001 | 0.061 | 0.308 |
Sleeping pillsa | −0.007 | 0.900 | - | - |
R2 | Â | 0.076 |